| Structure | Chemical Name | CAS | MF |
|
([125I]-TYR)-CALCITONIN N-TERMINAL FLANKING PEPTIDE (HUMAN)
|
|
|
|
([125I]-TYR0)-C-PEPTIDE (HUMAN)
|
|
C138H219IN36O50
|
|
|
([125I]-TYR)-CALCITONIN (EEL)
|
|
|
|
([125I]-TYR)-(CYS(ACM)20,31)-EGF (20-31)
|
|
C63H97IN16O23S3
|
|
([125I]-TYR)-CHOLECYSTOKININ OCTAPEPTIDE (DESULFATED)
|
|
C49H61IN10O13S2
|
|
|
([125I]-TYR)-CARDIODILATIN-RELATED PEPTIDE (HUMAN)
|
|
|
|
|
([125I]-TYR0)-CHROMOGRANIN A (240-288) (PORCINE)
|
|
|
|
|
([125I]-TYR)-C-TYPE NATRIURETIC PEPTIDE (1-53) (PORCINE, RAT)
|
|
|
|
([125I]-TYR)-CALCITONIN (HUMAN)
|
|
C151H225IN40O45S3
|
|
|
([125I]-TYR)-CALCITONIN (RAT)
|
|
|
|
|
([125I]-TYR)-C-TYPE NATRIURETIC PEPTIDE (1-29) (PORCINE, RAT)
|
|
|
|
([125I]-TYR0)-C-TYPE NATRIURETIC PEPTIDE (32-53) (HUMAN, PORCINE, RAT)
|
|
C102H165IN28O30S3
|
|
|
([125I]-TYR0)-CRF (HUMAN, RAT)
|
|
|
|
([125I]-TYR)-DYNORPHIN A (1-8)
|
|
C46H71IN14O10
|
|
([125I]-TYR)-DYNORPHIN B
|
|
C74H114IN21O17
|
|
|
([125I]-TYR)-(DES-BROMO)-NEUROPEPTIDE B (1-23) (HUMAN)
|
|
|
|
([125I]-TYR)-DYNORPHIN A (1-13)
|
|
C75H125IN24O15
|
|
([125I]-TYR)-(DES-GLY10,D-TRP6,PRO-NHET9)-LHRH
|
|
C64H82IN17O12
|
|
([125I]-TYR)-(D-ALA2,N-ME-PHE4,GLYCINOL5)-ENKEPHALIN
|
|
C26H34IN5O6
|
|
([125I]-TYR)-DYNORPHIN A (1-10) AMIDE
|
|
C57H91IN20O11
|
|
([125I]-TYR)-(DES-GLY10,D-LEU6,PRO-NHET9)-LHRH
|
|
C59H83IN16O12
|
|
([125I]-TYR)-DYNORPHIN A
|
|
C99H154IN31O23
|
|
|
([125I]-TYR)-DENDROASPIS NATRIURETIC PEPTIDE
|
|
|
|
([125I]-TYR)-ENDOTHELIN-2 (HUMAN, CANINE)
|
|
C115H159IN26O32S4
|
|
([125I]-TYR)-ENDOTHELIN-3 (HUMAN, MOUSE, RABBIT, RAT)
|
|
C121H167IN26O33S4
|
|
([125I]-TYR)-ENDOTHELIN-1 (HUMAN, BOVINE, DOG, MOUSE, PORCINE, RAT)
|
|
C109H158IN25O32S5
|
|
|
([125I]-TYR)-ENDOMORPHIN-2
|
|
|
|
([125I]-TYR0)-FMRFAMIDE
|
|
C38H50IN9O6S
|
|
|
([125I]-TYR)-GLP-1 (1-36) (HUMAN, BOVINE, GUINEA PIG, MOUSE, RAT)
|
|
|
|
|
([125I]-TYR)-GLUCAGON-37 (HUMAN, MOUSE, RAT)
|
|
|
|
([125I]-TYR)-GLP-1 (7-37) (HUMAN, BOVINE, GUINEA PIG, MOUSE, RAT)
|
|
C151H227IN40O47
|
|
([125I]-TYR)-GRP (PORCINE)
|
|
C126H197IN38O31S2
|
|
([125I]-TYR)-GALANIN (HUMAN)
|
|
C139H209IN42O43
|
|
([125I]-TYR)-GRP (14-27) (HUMAN, PORCINE, CANINE)
|
|
C75H109IN24O16S2
|
|
|
([125I]-TYR)-GAMMA2-MSH
|
|
|
|
([125I]-TYR)-GALANIN (RAT)
|
|
C141H210IN43O41
|
|
([125I]-TYR)-GRP (HUMAN)
|
|
C130H203IN38O31S2
|
|
([125I]-TYR)-GALANIN (PORCINE)
|
|
C146H212IN43O40
|
|
|
([125I]-TYR0)-GNRH PRECURSOR PEPTIDE (14-69) (HUMAN)
|
|
|
|
|
([125I]-TYR)-GASTRIN I (RAT)
|
|
|
|
|
([125I]-TYR)-GRF (RAT)
|
|
|
|
([125I]-TYR)-GASTRIN I (HUMAN)
|
|
C97H123IN20O31S
|
|
|
([125I]-TYR)-GLUCAGON (1-29) (HUMAN, BOVINE, PORCINE)
|
|
|
|
|
([125I]-TYR)-GASTRIC INHIBITORY POLYPEPTIDE (HUMAN)
|
|
|
|
|
([125I]-TYR)-GRF (HUMAN)
|
|
|
|
([125I]-TYR)-GONADORELIN
|
|
C55H74IN17O13
|
|
([125I]-TYR)-GLP-1 (7-36) AMIDE (HUMAN, BOVINE, GUINEA PIG, MOUSE, RAT)
|
|
C149H225IN40O45
|
|
|
([125I]-TYR0)-HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) (HUMAN, RAT)
|
|
|
|
|
([125I]-TYR)-HUMAN GROWTH HORMONE
|
|
|
|
|
([125I]-TYR)-HYPOCRETIN (28-66) (MOUSE, RAT)
|
|
|
|
|
([125I]-TYR)-IGF-I (30-41)
|
|
|
|
|
([125I]-TYR0)-INHIBIN ALPHA-SUBUNIT (1-32) (HUMAN)
|
|
|
|
|
([125I]-TYR)-INSULIN (HUMAN)
|
|
|
|
|
([125I]-TYR)-INTERMEDIN (RAT)
|
|
|
|
([125I]-TYR)-IGF-I (24-41)
|
|
C88H132IN27O28
|
|
|
([125I]-TYR0)-INHIBIN ALPHA-SUBUNIT (1-32) (PORCINE)
|
|
|
|
([125I]-TYR0)-KALIURETIC PEPTIDE (HUMAN)
|
|
C103H179IN32O30
|
|
([125I]-TYR)-LEUMORPHIN (HUMAN)
|
|
C150H223IN42O46
|
|
([125I]-TYR)-LEU-ENKEPHALIN
|
|
C28H36IN5O7
|
|
|
([125I]-TYR)-(LEU31,PRO34)-NEUROPEPTIDE Y (PORCINE)
|
|
|
|
|
Ivermectin B1a monosaccharide
|
|
|
|
|
Ivermectin aglycone
|
123997-59-1
|
|
|
|
IvermectinInjection1%-2%
|
|
|
|
|
IvermectinInjection
|
|
|
|
|
IvermectinE.P.
|
|
|
|
|
Ivermectin,Avermectin,Tiamulin
|
|
|
|
|
IvermectinMin97%Veterinary
|
|
|
|
|
IVERMECTIN POWDER
|
|
|
|
|
IVERMECTIN PREMIX
|
|
|
|
([125I]-TYR)-MET-ENKEPHALIN
|
|
C27H34IN5O7S
|
|
([125I]-TYR)-MET-ENKEPHALIN-ARG-GLY-LEU
|
|
C41H60IN11O10S
|
|
([125I]-TYR)-MALIGNANT MELANOMA METASTASIS-SUPPRESSOR KISS-1 (112-121) (HUMAN)
|
|
C63H81IN16O15
|
|
IVERMECTIN-B1A, [24,25-3H]
|
|
C48H72O14T2
|
|
Ivermectin
|
70288-86-7
|
C48H74O14
|
|
([125I]-TYR)-MET-ENKEPHALIN-ARG-PHE
|
|
C42H55IN10O9S
|
|
([125I]-TYR)-MATING FACTOR ALPHA
|
|
C82H113IN20O17S
|
|
([125I]-TYR)-MOTILIN (HUMAN, PORCINE)
|
|
C120H187IN34O35S
|
|
Ivermectin
|
70161-11-4
|
C48H74O14
|
|
|
Ivermectin Powder,Injection,Oral,Pour-on
|
|
|
|
|
Ivermectin B1
|
|
|
|
|
1% Ivermectin Injection
|
|
|
|
|
Ivermectin Injection 1% 10ml,50ml
|
|
|
|
|
IvermectinDrench
|
|
|
|
([125I]-TYR0)-NEUROKININ A
|
|
C59H88IN15O16S
|
|
|
([125I]-TYR)-NEUROPEPTIDE Y (PORCINE)
|
|
|
|
|
([125I]-TYR)-NEUROMEDIN U-25 (HUMAN)
|
|
|
|
|
([125I]-TYR)-NEUROPEPTIDE Y (HUMAN, RAT)
|
|
|
|
([125I]-TYR)-NEUROTENSIN
|
|
C78H120IN21O20
|
|
|
[125I](TYR1)NEUROPEPTIDE FF, HUMAN
|
|
|
|
|
([125I]-TYR)-NEUROMEDIN U-23 (RAT)
|
|
|
|
|
([125I]-TYR)-NICASTRIN (656-676) (HUMAN)
|
|
|
|
|
([125I]-TYR)-NICASTRIN (1-17) AMIDE (HUMAN)
|
|
|
|
|
([125I]-TYR)-(NLE21,TYR32)-CRF (OVINE)
|
|
|
|
([125I]-TYR0)-NEUROKININ B
|
|
C64H87IN14O16S2
|
|
|
([125I]-TYR)-NEUROPEPTIDE W-23 (HUMAN)
|
|
|
|
|
([125I]-TYR)-OSTEOGENIC GROWTH PEPTIDE
|
|
|
|
|
([125I]-TYR)-OREXIN A (HUMAN, BOVINE, MOUSE, RAT)
|
|
|
|
|
([125I]-TYR)-OSTEOCALCIN (1-49) (HUMAN)
|
|
|
|
([125I]-TYR)-OXYTOCIN
|
|
C43H65IN12O12S2
|
|
([125I]-TYR0)-OCTREOTIDE
|
|
C58H74IN11O12S2
|